Search Results - "Poston, Sara"

Refine Results
  1. 1

    Respiratory syncytial virus knowledge, attitudes, and perceptions among adults in the United States by La, Elizabeth M, Bunniran, Su, Garbinsky, Diana, Reynolds, Maria, Schwab, Phil, Poston, Sara, Harrington, Lauriane

    Published in Human vaccines & immunotherapeutics (31-12-2024)
    “…Respiratory syncytial virus (RSV) is associated with considerable morbidity and mortality among older adults (aged ≥60 years) and adults with certain chronic…”
    Get full text
    Journal Article
  2. 2

    Treatment patterns and clinical outcomes in patients with chronic immune thrombocytopenia (ITP) switched to eltrombopag or romiplostim by Kuter, David J., Macahilig, Cynthia, Grotzinger, Kelly M., Poston, Sara A., Wang, Peter Feng, Dawson, Katie L., Ward, Melea

    Published in International journal of hematology (01-03-2015)
    “…This observational study aimed to assess real-world treatment patterns and clinical outcomes for patients with chronic immune thrombocytopenia (ITP) currently…”
    Get full text
    Journal Article
  3. 3

    Modeled impact of the COVID-19 pandemic and associated reduction in adult vaccinations on herpes zoster in the United States by Curran, Desmond, La, Elizabeth M., Salem, Ahmed, Singer, David, Lecrenier, Nicolas, Poston, Sara

    Published in Human vaccines & immunotherapeutics (31-12-2022)
    “…Due to COVID-19, vaccinations dropped in 2020 and 2021. We estimated the impact of reduced recombinant zoster vaccine (RZV) use on herpes zoster (HZ) cases,…”
    Get full text
    Journal Article
  4. 4

    Impact of population aging on the burden of vaccine-preventable diseases among older adults in the United States by Talbird, Sandra E, La, Elizabeth M, Carrico, Justin, Poston, Sara, Poirrier, Jean-Etienne, DeMartino, Jessica K, Hogea, Cosmina S

    Published in Human vaccines & immunotherapeutics (01-02-2021)
    “…Despite vaccination recommendations, the burden of vaccine-preventable diseases remains high in older adults in the United States (US), contributing to…”
    Get full text
    Journal Article
  5. 5

    Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States by Molnar, Daniel, La, Elizabeth M., Verelst, Frederik, Poston, Sara, Graham, Jonathan, Van Bellinghen, Laure-Anne, Curran, Desmond

    Published in Infectious diseases and therapy (01-04-2024)
    “…Introduction Respiratory syncytial virus (RSV) is an important cause of lower respiratory tract disease in older adults, resulting in substantial morbidity and…”
    Get full text
    Journal Article
  6. 6

    Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer by Curran, Desmond, Patterson, Brandon J., Carrico, Justin, Salem, Ahmed, La, Elizabeth M., Lorenc, Stéphane, Hicks, Katherine A., Poston, Sara, Carpenter, Christopher F.

    Published in Human vaccines & immunotherapeutics (31-12-2023)
    “…Individuals who are immunocompromised (IC) due to therapy or underlying disease are at increased risk of herpes zoster (HZ). This study evaluates the public…”
    Get full text
    Journal Article
  7. 7

    Burden of Herpes Zoster Among Patients with Psoriasis in the United States by Singer, David, Thompson-Leduc, Philippe, Ma, Siyu, Gupta, Deepshekhar, Cheng, Wendy Y., Sendhil, Selvam R., Sundar, Manasvi, Hagopian, Ella, Stempniewicz, Nikita, Duh, Mei Sheng, Poston, Sara

    Published in Dermatology and therapy (01-11-2023)
    “…Introduction Patients with psoriasis (PsO) are at increased risk of herpes zoster (HZ), but recent data on the incidence of HZ among patients with PsO and the…”
    Get full text
    Journal Article
  8. 8

    Herpes zoster burden in patients with asthma: real-world incidence, healthcare resource utilisation and cost by Singer, David, Thompson-Leduc, Philippe, Ma, Siyu, Gupta, Deepshekhar, Cheng, Wendy Y, Muthukumar, Aruna, Devine, Francesca, Sundar, Manasvi, Bogart, Michael, Hagopian, Ella, Poston, Sara, Duh, Mei Sheng, Oppenheimer, John J

    Published in BMJ open respiratory research (11-06-2024)
    “…BackgroundHerpes zoster (HZ) is a painful condition caused by reactivation of the varicella-zoster virus. The objectives of this study were to compare HZ…”
    Get full text
    Journal Article
  9. 9

    Evaluation of Clinical Outcomes With Alvimopan in Clinical Practice: A National Matched-Cohort Study in Patients Undergoing Bowel Resection by DELANEY, Conor P, CRAVER, Christopher, GIBBONS, Melinda M, RACHFAL, Amy W, VANDEPOL, Christine J, COOK, Suzanne F, POSTON, Sara A, CALLOWAY, Michael, TECHNER, Lee

    Published in Annals of surgery (01-04-2012)
    “…To evaluate in-hospital clinical outcomes after open and laparoscopic bowel resection (BR) with or without alvimopan treatment. Delayed return of…”
    Get full text
    Journal Article
  10. 10

    Clinical and Economic Burden of Herpes Zoster in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study Using Administrative Claims by Singer, David, Thompson-Leduc, Philippe, Poston, Sara, Gupta, Deepshekhar, Cheng, Wendy Y., Ma, Siyu, Devine, Francesca, Enrique, Alexandra, Duh, Mei Sheng, Curtis, Jeffrey R.

    Published in Rheumatology and therapy. (01-08-2023)
    “…Objective To estimate the incremental healthcare resource utilization (HRU) and cost burden posed by herpes zoster (HZ) in adult patients with rheumatoid…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Economic analysis of alvimopan in North American Phase III efficacy trials by Bell, Timothy J, Poston, Sara A, Kraft, Michael D, Senagore, Anthony J, Delaney, Conor P, Techner, Lee

    Published in American journal of health-system pharmacy (01-08-2009)
    “…The economic effect of the use of alvimopan in four randomized, double-blind, placebo-controlled, Phase III, North American efficacy trials was analyzed…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Vaccination in Older Adults: The When and Where by Poston, Sara

    Published in Innovation in aging (16-12-2020)
    “…Abstract Despite the well-understood benefits of vaccination in older adults, national rates still fall below public health targets, especially among certain…”
    Get full text
    Journal Article
  16. 16

    1045-P: Cost-Effectiveness of Adjuvanted RSVPreF3 Vaccination in Adults Aged 50–59 Years with Diabetes in the United States by Singer, David, La, Elizabeth, Graham, Jonathan, Grace, Mei, Poston, Sara, Molnar, Daniel

    Published in Diabetes (New York, N.Y.) (01-06-2024)
    “…Introduction & Objective: Older adults and adults with comorbidities, such as metabolic diseases, are at increased risk of severe respiratory syncytial virus…”
    Get full text
    Journal Article
  17. 17

    Cefazolin Tolerance Does Not Predict Ceftriaxone Hypersensitivity: Unique Side Chains Precipitate Anaphylaxis by Poston, Sara A., Jennings, Heath R., Poe, Kevin L.

    Published in Pharmacotherapy (01-05-2004)
    “…A 48‐year‐old woman with a questionable history of an unspecified ceftriaxone allergy was treated with cefazolin for surgical antibiotic prophylaxis. After she…”
    Get full text
    Journal Article
  18. 18

    524-P: Knowledge, Attitudes, and Perceptions of Respiratory Syncytial Virus (RSV) among U.S. Adults with Diabetes by LA, ELIZABETH, BUNNIRAN, SUVAPUN, GARBINSKY, DIANA, REYNOLDS, MARIA, POSTON, SARA, HARRINGTON, LAURIANE

    Published in Diabetes (New York, N.Y.) (20-06-2023)
    “…Rationale: Risk of complications and severe outcomes from respiratory syncytial virus (RSV) infection is increased in older adults and adults with certain…”
    Get full text
    Journal Article
  19. 19

    The Potential Impact of Increased Recombinant Zoster Vaccine Coverage on the Burden of Herpes Zoster Among Adults Aged 50–59 Years by Singer, David, Salem, Ahmed, Stempniewicz, Nikita, Ma, Siyu, Poston, Sara, Curran, Desmond

    Published in Vaccine (23-08-2023)
    “…•3–5 bullets, max 85 characters including spaces per bullet.•Recombinant zoster vaccine (RZV) is recommended by ACIP for US adults aged ≥50 years.•Vaccination…”
    Get full text
    Journal Article
  20. 20

    Topiramate prescribing patterns among medicaid patients: Diagnosis, comorbidities, and dosing by Poston, Sara, PharmD, Dickson, Michael, PhD, Johnsrud, Michael, PhD, Rupnow, Marcia F.T., PhD, Gdovin, Joette M., PhD, MPA, Bramley, Thomas J., PhD, Armstrong, Robert B., MD

    Published in Clinical therapeutics (01-03-2007)
    “…Abstract Background: Routine clinical practice data are useful for payers and formulary decision makers to make sound decisions regarding coverage policy…”
    Get full text
    Journal Article